2025 is nearly here. And while many on this platform (including me) penned 2025 outlooks for the S&P 500 for the coming year, ...

This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

Newmont Corporation is a 'Strong Buy' due to its dominant position in gold mining and solid copper exposure, with favorable ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

Here are some stocks to watch on Thursday: ) said it was disappointed by the decision. "Taiwan is still one of the global markets with the highest growth and full of food delivery business ...

Pathward's business has an unusually heavy reliance on debit card fee income which has helped it deliver great value to ...

Despite improved fundamentals, J&J Snack Foods underperformed, with shares down 0.6% while the S&P 500 rose 9.2%, justifying a 'hold' rating. Read more here.

Discover the investment potential of AMN Healthcare Services with innovative staffing solutions and strategic business model, ...

The Dividend Harvesting Portfolio remains profitable, despite recent declines, generating $1,908.79 in forward dividend ...

Roku remains attractively valued despite recent rally, driven by its nascent advertising opportunities and partnerships. Find ...

BJ's current valuation is 30% above its five-year average, presenting a bad risk/reward ratio; I downgrade the stock to 'Sell ...

Kraft Heinz shares dropped 17% in 2024, but a 5.2% dividend yield makes it attractive for dividend investors despite ...